December 11, 2025

What Drives Progression Despite TNFi?

Study shows complement activation marker C3dg, MASP-1, and MASP-3 levels before tumor necrosis factor inhibitor therapy predicted new bone formation after 2 years of follow-up among axial spondyloarthritis patients with a high risk of radiographic progression.

Conexiant

December 10, 2025

A New Question for Chronic Pain

A new clinical feature–based self-referral tool shows promise for speeding the diagnosis of axial spondyloarthritis.

Conexiant

December 05, 2025

Top 10 States to Practice Rheumatology

The following list highlights the states that offer the most favorable conditions for rheumatologists.

Conexiant

December 01, 2025

Childhood Sjögren's Shows Dual Trajectories

Lymphoma rate reaches 13% in single-center UK cohort tracked up to 25 years; damage accumulation predominantly glandular

Conexiant

November 26, 2025

FDA Grants Accelerated Approval of Voyxact

The subcutaneous injection offers a new option for adults at risk of progression to kidney failure.

Conexiant

November 19, 2025

Beyond Lupus: Anti-C1q’s Wider Role

Elevated antibody detection was observed across a range of autoimmune conditions.

Conexiant

November 17, 2025

Active PsA Linked to Maternal Hypertension in Pregnancy

Researchers explore links between psoriatic arthritis and maternal health.

Conexiant

September 03, 2025

Policy Shift Adjusts NIH Peer Review Role

New NIH funding rules shift decision-making power from peer review panels to political appointees in determining future scientific grants.

KFF Health News

September 12, 2025

FDA Considers Ending Routine Advisory Committees on New Drugs

The FDA move to limit advisory committee involvement in drug approvals has prompted debate on the balance between efficiency and transparency.

KFF Health News